new labeling about the possible cardiovascular risk related to Avandia and other diabetes meds

December 2007

You'll see new labeling about the possible cardiovascular risk related to Avandia and other diabetes meds.

These will go beyond Avandia's and Actos's current black box warning about edema and heart failure.

The new warning will focus on whether Avandia increases the risk of ischemic events...angina and heart attacks.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote